Bryant Summers | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Bryant Summers
The Ohio State University

Bryant Summers
Affiliation The Ohio State University
Country United States
Scopus ID 56339860000
Documents 12
Citations 89
h-index 5
Subject Area Medicine and Health Sciences
Event International PopularScientist Awards

Bryant Summers is a researcher affiliated with The Ohio State University whose supplied bibliometric profile places the work within Medicine and Health Sciences. The profile records 12 documents, 89 citations, and an h-index of 5. These indicators provide a quantitative description of the supplied publication record and can be considered alongside publication topics, scholarly contributions, and the relevance of individual research outputs. The recognition context is the International PopularScientist Awards.

Abstract

Bryant Summers is presented in the supplied recognition profile as a Medicine and Health Sciences researcher affiliated with The Ohio State University in the United States. The supplied Scopus identification number is 56339860000, with a reported publication record of 12 documents, 89 citations, and an h-index of 5. These bibliometric measures provide a concise quantitative view of the research record. The supplied publication information also identifies scholarship concerning kidney-function estimation and medication-related decision-making as part of the broader evidence base relevant to contemporary clinical pharmacy and health sciences research.

Keywords

  • Medicine and Health Sciences
  • Clinical Pharmacy
  • Kidney Function
  • Estimated Glomerular Filtration Rate
  • Medication-Related Decision-Making
  • Research Impact
  • Bibliometrics

Introduction

Research in medicine and health sciences frequently connects clinical evidence, pharmacotherapy, kidney function assessment, and methods for supporting treatment decisions. One supplied publication associated with this research context is the 2026 article titled “Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” The article was published in the Journal of the American College of Clinical Pharmacy, volume 9, issue 2, as article e70153. [2]

Research Profile

The supplied researcher profile identifies Bryant Summers with The Ohio State University and places the research activity in Medicine and Health Sciences. The reported Scopus identifier is 56339860000. The supplied bibliometric figures are 12 documents, 89 citations, and an h-index of 5. Scopus author identifiers and bibliometric indicators are useful for distinguishing an author’s indexed publication record and summarizing citation activity, although such indicators represent only selected quantitative dimensions of scholarly work. [1]

Research Contributions

The supplied publication title identifies a research discussion focused on estimated glomerular filtration rate and medication-related decision-making. The associated article describes the transition toward race-free eGFR approaches and considers how contemporary kidney-function assessment can be incorporated into clinical pharmacy practice. [2] The topic is relevant to medication dosing, renal function assessment, clinical decision support, and the development of standardized healthcare practices.

Publications

The supplied publication material includes a 2026 article concerning race-free estimated glomerular filtration rate and medication-related decision-making. The article is identified in the journal record as a review and opinion contribution associated with the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. [2]

  • Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 9(2), e70153.

Research Impact

The supplied bibliometric profile reports 89 citations across 12 documents and an h-index of 5. These figures indicate that the indexed publication record has accumulated measurable citation activity. [1] Bibliometric indicators should be interpreted in relation to field-specific publication practices, database coverage, authorship patterns, publication age, and the qualitative significance of individual contributions.

Award Suitability

The supplied profile contains several documented elements that can be considered in an academic recognition review, including an institutional affiliation, a Scopus author identifier, publication and citation metrics, and a defined subject area. The publication material supplied for this profile also demonstrates engagement with a contemporary clinical topic involving renal function estimation and medication-related decision-making.

Conclusion

Bryant Summers is presented in the supplied profile as a Medicine and Health Sciences researcher affiliated with The Ohio State University. The reported record comprises 12 documents, 89 citations, and an h-index of 5, with Scopus Author ID 56339860000. The supplied publication context concerns kidney-function estimation and medication-related decision-making, including contemporary discussion of race-free estimated glomerular filtration rate and its implementation in clinical pharmacy practice. [1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Bryant Summers, Author ID 56339860000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56339860000
  2. Wallace, J. L., Rungkitwattanakul, D., Khan, R. W., Anderson, L., Anderson, E. R., El Nekidy, W. S., Nemecek, B. D., Meaney, C. J., Prasad-Reddy, L., Salama, L., Hudson, J. Q., Kane-Gill, S. L., Barreto, E. F., Bzowyckyj, A. S., & St. Peter, W. (2026). Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 9(2), e70153.
    https://doi.org/10.1002/jac5.70153
  3. Pierce, D., Brokhof, M. M., Fredrick, S. R., et al. (2026). Comment on “Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” Journal of the American College of Clinical Pharmacy.
    https://doi.org/10.1002/jac5.70201
  4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117–S314.
    https://doi.org/10.1016/j.kint.2023.10.018
  5. St. Peter, W. L., Bzowyckyj, A. S., Anderson-Haag, T., et al. (2024). Moving Forward From Cockcroft-Gault Creatinine Clearance to Race-Free Estimated Glomerular Filtration Rate to Improve Medication-Related Decision-Making in Adults Across Healthcare Settings. American Journal of Health-System Pharmacy, 82, zxae317.
    https://doi.org/10.1093/ajhp/zxae317

Fanny Lemarié | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.